| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |